Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

146.03 -0.41 (-0.28%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,491,990
Open 146.43
Bid (Size) 145.90 (3)
Ask (Size) 146.03 (17)
Prev. Close 146.44
Today's Range 145.74 - 147.15
52wk Range 143.13 - 175.97
Shares Outstanding 2,628,679,824
Dividend Yield 3.26%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven
These Dividend Aristocrats all have payouts yielding three times or more the average yield of the S&P 500. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
Johnson & Johnson announced Phase 3 CARTITUDE-4 study results showing Carvykti significantly improves overall survival in relapsed or lenalidomide-refractory multiple myeloma after one prior line of... 
Via Benzinga

Performance

YTD
-8.71%
-8.71%
1 Month
-1.16%
-1.16%
3 Month
-7.42%
-7.42%
6 Month
-8.71%
-8.71%
1 Year
-10.60%
-10.60%

More News

Read More
Court Rules Against Johnson & Johnson In Talcum Powder Cancer Study Case
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
JNJ Should Rally Soon Or See 3 Swings Higher At Least
Via Talk Markets
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Via Benzinga
Topics Stocks
Exposures US Equities
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
Via Benzinga
"Rule Breaker Investing" Mailbag: Talking Stocks and Options
Via The Motley Fool
3 Retirement All-Stars for Steady Growth and Income
Via InvestorPlace
Topics Retirement
Exposures Pension
3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks
Via InvestorPlace
Judge Blocks Cancer Victims' Attempt To Stop Johnson & Johnson Bankruptcy Plan
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Legal
3 Magnificent Stocks Retirees Can Buy and Hold Forever
Via The Motley Fool
Exploring NYSE:JNJ's dividend characteristics.
Via Chartmill
Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.
Via InvestorPlace
Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
Via The Motley Fool
4 Cheap Stocks to Buy in July
Via The Motley Fool
10 Blue-Chip Dividend Growth Stocks With 3% Yields And Safe Dividends
Via Talk Markets
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Lawyers for Johnson & Johnson’s Ovarian Cancer Victims React to SCOTUS Decision in Purdue
From Beasley Allen
Via Business Wire
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
Via Benzinga
Exposures Product Safety
2 Incredible Dividend Growth Stocks to Buy Right Now
Via The Motley Fool
Is Johnson & Johnson Stock a Buy?
Via The Motley Fool
The 3 Smartest Dow Stocks to Buy With $1000 Right Now
Via InvestorPlace
Topics Stocks
Exposures US Equities
Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.